By: IPP Bureau
Last updated : November 05, 2021 11:30 pm
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
Dr Reddy’s reported a total income of Rs. 5992.4 crores during the period ended September 30, 2021, as compared to Rs. 5053 crores during the period ended June 30, 2021. The company has reported a total income of Rs.4962.1 crore during the period ended September 30, 2020.
Dr Reddy’s has posted a net profit of Rs. 992 crores for the period ended September 30, 2021, as against a net profit of Rs. 570.8 crores for the period ended June 30, 2021.The company has posted a net profit of Rs.762.3 crore for the period ended September 30, 2020.
The company has reported a total income of Rs.11045.4 crore during the 6 months ended September 30, 2021, as compared to Rs.9475.7 crores during the 6 months ended September 30, 2020.
The company has posted net profit of Rs.1562.8 crores for the 6 months ended September 30, 2021, as against net profit of Rs.1341.6 crores for the 6 months ended September 30, 2020.
Commenting on the results, Co-Chairman & MD, G V Prasad said “I am pleased with the improvement in the financial performance across our businesses. While we continue to strengthen our core businesses of generics and APIs, we are also making investments in our long-term growth drivers and deeper innovation capabilities. Our focus remains on meeting unmet patient needs around the world in keeping with our purpose”.